Visteon — Feb 19, 2026 release

Because not all companies use identical calculations, this presentation of adjusted EBITDA may not be comparable to similarly titled measures of other companies. Three Months Ended Twelve Months Ended Estimated December 31, December 31, Full Year Visteon : 2025 2024 2025 2024 2026 Net income (loss) attributable to Visteon Corporation* $ 74  $ 125  $ 201  $ 296  $ 205    Depreciation and amortization 29  25  109  96  120    Restructuring, net 4  1  8  32  10  Provision for (benefit from) income tax* (13) (44) 125  (8) 90    Non-cash, stock-based compensation expense 11  10  45  41  50    Interest (income) expense, net (3) (2) (9) (2) (5)   Net income (loss) attributable to non-controlling interests 4  3  12  10  10    Equity in net loss (income) of non-consolidated affiliates (3) (4) (8) 3  (10)   Other, net 7  3  9  6  5  Adjusted EBITDA $ 110  $ 117  $ 492  $ 474  $ 475    1 *Amounts shown reflect the change in accounting principle related to the method for assessing the realizability of U.S. deferred tax assets described in the Company's 2025 Form 10-K. Adjusted EBITDA is not a recognized term under U.S. GAAP and does not purport to be a substitute for net income as an indicator of operating performance or cash flows from operating activities as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and is not intended to be a measure of cash flow available for management's discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements. In addi